Source: 4-TRADERS

AtheroMed: Volcano : Inks Agreement to Buy AtheroMed

(4-traders.com) Volcano Corp. said it has signed an agreement to acquire AtheroMed, a privately-held company that has developed the Phoenix Atherectomy System used in the treatment of peripheral artery disease (PAD). According to a company release on May 27, the Phoenix, which received 510(k) clearance in January 2014 and has a CE Mark, enables physicians to...http://www.4-traders.com/VOLCANO-CORPORATION-17313/news/Volcano--Inks-Agreement-to-Buy-AtheroMed-18525799/

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael T. MacKinnon's photo - President & CEO of AtheroMed

President & CEO

Michael T. MacKinnon

CEO Approval Rating

70/100

Read more